Clinical trial

Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer Radiotherapy

NCT03416972

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

RADIATION · Unmapped registry intervention Standard platinum-based chemoradiotherapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer Radiotherapy

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2018-01-11

PhaseN/A

Conditions

Non-small Cell Lung Cancerverified · MONDO: non-small cell lung carcinoma

Radiation Toxicityunresolved

Interventions

Standard platinum-based chemoradiotherapyRADIATION

Sponsors & collaborators

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'slead sponsor

Canadian Institutes of Health Research (CIHR)collaborator

Mapped research locations

LondonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03416972 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.